Back
Replimune Group Vs. Pfizer Industry Stock Comparison
Sell
29
REPL
Replimune Group
Last Price:
12.65
Seasonality Move:
-15.42%
Sell
32
PFE
Pfizer
Last Price:
25.23
Seasonality Move:
0.94%
Sell
29
Replimune Group (REPL)
is a Sell
Is Replimune Group a Buy, Sell or Hold?
- The current Replimune Group [REPL] share price is $12.64. The Score for REPL is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- REPL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Pfizer (PFE)
is a Sell
Is Pfizer a Buy, Sell or Hold?
- The current Pfizer [PFE] share price is $25.23. The Score for PFE is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- PFE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REPL Stock Price Chart
What is Replimune Group's stock price today?
-
The Replimune Group share price today is $12.64
The current trend is moderately bearish and REPL is experiencing selling pressure, which indicates risk of future bearish movement.
PFE Stock Price Chart
REPL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 50.11 | Buy |
| Chaikin Money Flow: | -412486 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.47 - 13.71) | Buy |
| Bollinger Bands (100): | (10.06 - 12.42) | Buy |
PFE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.46 | Sell |
| Relative Strength Index (14 RSI): | 39.4 | Sell |
| Chaikin Money Flow: | -25693313 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.15 - 26.53) | Sell |
| Bollinger Bands (100): | (26.73 - 29.91) | Sell |
REPL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.01 | Sell |
| 20-day SMA: | 12.64 | Buy |
| 50-day SMA: | 12.14 | Buy |
| 200-day SMA: | 9.46 | Buy |
| 8-day EMA: | 12.94 | Sell |
| 20-day EMA: | 12.78 | Sell |
| 50-day EMA: | 12.16 | Buy |
| 200-day EMA: | 10.92 | Buy |
PFE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.62 | Sell |
| 20-day SMA: | 25.61 | Sell |
| 50-day SMA: | 27.33 | Sell |
| 200-day SMA: | 27.99 | Sell |
| 8-day EMA: | 25.62 | Sell |
| 20-day EMA: | 25.93 | Sell |
| 50-day EMA: | 26.9 | Sell |
| 200-day EMA: | 28.55 | Sell |
Replimune Group Earnings Growth & REPL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.52 per share.
Pfizer Earnings Growth & PFE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and a decrease next year of $0.05 per share.
Replimune Group Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pfizer Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||